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INTRODUCTION1-8 
QUINAZOLINES 
Quinazoline is a fused bicycle compound earlier known as benzo-1, 
3-diazine. It was first prepared in the laboratory by Gabriel in 1903. One of 
its derivatives named 2-cyanoquinazolinone known much earlier was 
prepared from anthranilic acid and cyanogens.                          
N
N                                             
NH
N
O
CN 
               Quinazoline                                         2-cyanoquinazolinone 
           Paal and Bush suggested the numbering of quinazoline ring 
system, which is currently used. 
5
8
6
7
N
3
2
4
N
1  
           The other less commonly used names for this ring system are 
phenmiazine and 5,6-benzopyrimidine. However, the name quinazoline is 
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now universally accepted. 
           The presence of a fused benzene ring alters the properties of the 
pyrimidine ring considerably. The two nitrogen atoms are not equivalent 
and the marked polarization of the 3, 4-double bond is reflected in the 
reactions of quinazolines.  
The properties of the substituted quinazolines depends on: 
a) Nature of the substituents 
b) Whether they are in the pyrimidine ring or the benzene ring 
c) Whether or not complete conjugation is present in the pyrimidine 
ring.  
METHODS TO PREPARE QUINAZOLINES: 
I. From  2-aminobenzonitrile  
1) With Grignard reagent: 
2, 4-Disubstituted quinazolines are synthesized by the treatment of 
2-aminobenzonitrile with Grignard’s reagent where an intermediate is 
formed and this intermediate further reacts with acid chloride to give 
substituted quinazolinone.  
  
CN
NH2
NMgBr
CH3
NMgBr
CH3MgBr C6H5COCl
N
N
CH3
2-aminobenzonitrile
4-methyl-2-phenylquinazoline
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2) With anilines in the presence of aluminium chloride: 
2-Aminobenzonitriles was treated with anilines in the presence of 
aluminium chloride to give an intermediate 2-amino-N-arylbenzamidines 
which when treated with formic acid gave 4-aryl aminoquinazolines. 
 
CN
NH2
NH2
N
NH2
NH
NH
N
HCOOH
NH2
N-phenyl-3,4-dihydroquinazolin-4-amine2-amino-N'-phenylbenzenecarboximidamide
2-aminobenzonitrile
 
 
3) In mild conditions: 
Treatment of 2-aminobenzonitrile with carbon monoxide, sulphur 
and potassium carbonate in dimethylformamide at 1atm and 200C. 
NH2
N N
N OH
SH
CO, S, K2CO3
DMF, 1atm, 200C
4-sulfanylquinazolin-2-ol2-aminobenzonitrile  
 
II. From N- arylbenzamides: 
N-arylbenzamides when treated with phosphorus pentachloride 
yielded the corresponding N-arylbenzimidoyl chlorides which on treatment 
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with cyanamide yielded diaza-1, 3-butadiene as intermediates. Finally the 
diaza-1,3-butadiene upon the treatment with TiCl4 underwent cyclisation to 
give the 2,4-disubstituted quinazolinones. 
  
NH
O
R
1
NH
Cl
R
1
N
N
R
1
NH2
Cl
1. TiCl4 
2. NaOH
N
N
NH2
R
1
PCl5 N NH2
 
III. From 2- fluorobenzaldehydes: 
2-Fluorobenzaldehydes which is activated by either a cyano or a 
nitro at the 5th position when treated with ethanimidamine forms  
2-methylquinazoline 6-carbonitrile. 
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F
H
ON
4-fluoro-3-formylbenzonitrile
+ CH3
NH
NH2
ethanimidamide
N CH3
NH
F
N
condensation
(-H2O)
K2CO3
SNAr
N
N
N
CH3
2-methylquinazoline-6-carbonitrile  
 
 
NATURAL SUBSTANCES CONTAINING THE QUINAZOLINE 
NUCLEUS: 
Quinazoline alkaloids constitute a moderately sized group of natural 
products. These are some of the examples of alkaloids with the 
quinazoline moiety. 
¾ Chrysogine: 
This mould metabolite was isolated in 1973 by Hikino et al. from 
strains of Penicillium chrysogenum. 
NH
N
CH3
OH
O
H
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¾ Luotonin A: 
This quinazoline alkaloid was isolated from the aerial parts of 
Peganum nigellastrum, a plant that has been used in traditional Chinese 
medicine as anti inflammatory. 
N
N N
O
 
¾ Trypthanthrin: 
This molecule was identified as a natural product from the plant kingdom 
in 1977 by Bergman et al. when it was isolated from the fruits of the 
cannon ball tree, Couropita quianensis. 
N N
O
O
 
¾ Febrifugine: 
This alkaloid was isolated from the Chinese plant Dichroafebrifuga. 
These highly toxic molecules have attracted attention due to their potential 
anti malarial activity coupled with intricate structural problems of these 
relatively unstable compounds. 
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N
N
N
H
OH
O
O
 
MEDICINAL QUINAZOLINE COMPOUNDS:                                                      
             The quinazoline skeleton is present in a variety of biologically 
active compounds, among these are several marketed drugs. 
¾ Anti Hypertensive Drugs 
 Alfuzosine Hydrochloride: 
N
N N
CH3
NH
O
O
O
O
CH3
NH2
CH3
 
 Prazosine Hydrochloride: 
N
N N
N
O
O
O
CH3
O
NH2
CH3
 
 Doxazosine mesylate: 
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N
N N
N
O
O
O
O
CH3
O
CH3
NH2
 
 Terazosine hydrochloride: 
N
N N
N
O
O
O
CH3
O
CH3
NH2
 
 
 
 
¾ Dihydrofolate Reductase Inhibitor 
 Trimetrexate glucuronate: 
O
CH3
O
CH3
NH N
N
CH3 NH2
NH2
O
CH3
 
QUINAZOLINONES:                                                                
          Of the many derivatives of quinazoline system known so far, keto-
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quinazolines also called as quinazolinones, are the most important 
compounds. Depending upon the position of the keto or oxo group, these 
compounds may be classified into two types: 
 2(1H) quinazolinones (or) 1,2-dihydro-2-oxo quinazolines  
 4(3H)-quinazolines (or) 3,4-dihydro-oxoquinazolines.  
NH
N
O
                                       
N
N
H
O
 
      Quinazoline-4(3H)-one                                  Quinazoline-2(1H)-one 
2-Cyano-4(3H)-quinazolinone was the first quinazolinone derivative 
to be synthesized. 
NH
N
O
CN 
Brief  account of reactivity of 4(3H)-Quinazolinones: 
The amide linkage of quinazolinone show keto-enol tautomerism 
and the reaction characters of both keto and enol forms. 
NH
N
O
N
N
OH
 
                                     Keto form                           Enol form                              
Physical properties: 
Quinazolinones are high melting crystalline solids, insoluble in 
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water and in most organic solvents but soluble in aqueous alkali. They are 
generally insoluble in dilute acids but are sometimes soluble in 
concentrated acids. 4(3H)-quinazolinones, although insoluble in dilute 
acids, are soluble in 6N hydrochloric acid. 4(3H)-quinazolinones form 
stable monohydrochlorides, chloroplatinate, chloroaurates and picrates 
and metal salts of silver, mercury, zinc, copper, sodium and potassium. 
Stability of the ring system: 
The ring system in quinazolinone is exceedingly stable in oxidation, 
reduction, hydrolysis reactions and other treatment designed to break the 
ring. There is no report of degradation of quinazolinone by simple chemical 
oxidation. 
 
 
Aromatisation: 
When 4-quinazolinone is heated with an equivalent amount of 
phosphorous pentachloride in phosphorous oxychloride, the corresponding 
4-chloroquinazoline  is obtained.  
NH
N
O
CH3
N
N
Cl
PCl5
POCl3  
 Nitration: 
4(3H)-Quinazolinone on boiling with nitric acid undergoes 
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substitution to give 6-nitro-4-quinazolinone. On further nitration the second 
nitro group enters the 8-position to give 6, 8-dinitro derivatives. 
  
NH
N
O
H2SO4
HNO4
NH
N
O
O2N H2SO4
HNO4
NH
N
O
O2N
NO2
6,8-dinitroquinazolin-4(3H)-one
6-nitroquinazolin-4(3H)-onequinazolin-4(3H)-one
 
Reduction: 
2, 3-Dihydro-3-methyl- 4(1H)-quinazolinone could be obtained on 
reduction of 3-methyl-4(3H)-quinazolinone with Lithium Aluminium Hydride 
(LiAIH4) in benzene. 
N
N
H
O
CH3
N
N
O
CH3 LiAlH4
3-methyl-2,3-dihydroquinazolin-4(1H)-one3-methylquinazolin-4(3H)-one  
Methods of preparation of 4(3H)-Quinazolinones: 
Most of the methods employed for the synthesis of 4(3H)-
quinazolinones make use of anthranilic acid or one of their functional 
derivatives as the starting materials. Based on this factor, the general 
methods of synthesis are: 
a. Condensation of anthranilic acid with acid amides: 
When anthranilic acid is heated in an open container with excess of 
formamide at 120°C, water is expelled and a nearly quantitative (90%) 
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conversion to 4(3H)-quinazolinones is achieved. 
OH
O
NH2
NH
N
O
HCONH2
Δ 120οC
 
b. Condensation of acetanilides with urethanes: 
Urethane and acetanilide on heating for 3 hours with phosphorus 
pentoxide in toluene gave 2-methyl-4(3H)-quinazolinone. 
NH2
O CH3
O
methyl carbamate
NH CH3
O
N-phenylacetamide
+ PO5
toluene
NH
N CH3
O
 
c. Oxidative hydration of o- aminobenzonitriles          
o-Amino benzonitriles when treated with urea hydrogen 
peroxide(UHP) yields quinazoline-4(3H)-one. 
 
R1=COR4 
Reagents and conditions: (a)-UPH, cat. K2CO3, acetone :water(1:1), 
reflux. 
d. From anthranilamide: 
Carboxylic acid derivative of quinazolinones is prepared from 
anthranilamide and benzoic anhydride, succinic anhydride, etc, which 
2-methyl-4(3H)-quinazolinone
    P2 5 
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upon treatment with aqueous sodium hydroxide afforded the desired 
quinazolinones. 
  
NH2
O
NH2
NH
N
O
R
1
1)Various anhydrides and oxalates
2) Aqueous NaOH
 
Where; R1= phenyl, CO2Et, (CH3)2COOH, (CH2)3COOH 
e. Hetero-Diels-alder synthesis of 2-substituted-quinazolinones: 
The synthesis of 2- substituted quinazolinones by the cyclisation of 
1- aryl-4-dimethylamino-2-phenyl-1, 3-diaza-1, 3-butadienes and phenyl 
isocyanate was reported by Croce et al. The reaction was carried out 
under an atmosphere of nitrogen in toluene at reflux temperature, to 
furnish the desired products in good yields. The presence of the electron 
rich dimethyl amino group on the diene destabilizes the cycloaddition 
adduct, facilitating the elimination of the N, N-dimethyl-N’-
phenylformamidine as a side product.   
          
N
N
Ph
N
CH3CH3
R
+ N OPh
NH
N
O
Ph
R
+
N
CH3CH3
N
Ph
 
f. Niementowski Quinazoline Synthesis: 
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Formation of 4-oxo-3,4-dihydroquinazolines by cyclization of 
anthranilic acid and amides. 
 
g. Grimmel,Guenther and Morgan’s synthesis: 
3 moles of o-amido benzoic acids,when heated with 3 moles of an 
amine together with one mole of phosphorous trichloride in toluene for two 
hours,gave high yields of 2,3-disubstituted 3,4-dihydro-4-oxoquinazolines. 
 
 
MEDICINAL DRUGS CONTAINING QUINAZOLINONE NUCLEUS:                                      
 Methaqualone: 
N
N
O
CH3
CH3
 
This compound was introduced in 1965 as a safe barbiturate 
substitute. 
 Raltitrexed:  
CO2H 
NHCOR 
3R′NH2 + PCl3 
N
N
3 + 
O
R’ 
R 
  
3 
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NH
N
N
CH3
S
NH
OH
O
O
OH
CH3
O
O
 
Thymidylate synthetase inhibitor (launched in 1996). 
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¾ CENTRALLY ACTING MUSCLE RELAXANT 
 Afloqualone: 
N
N
F
CH3
O
NH2
 
 Chloroqualone: 
Cl
N
N
CH3
Cl
O
 
 Diproqualone:  
N
N CH3
O
OH
OH
 
                  
BIOLOGICAL IMPORTANCE OF 4-QUINAZOLINONES: 
The quinazolinone skeleton is a frequently encountered hetrocycle 
in medicinal chemistry with activities including antibacterial9-17,  
antifungal 18-22, analgesic and anti inflammatory23-27, anticonvulsant28,29, 
antihypertensive30, antimalarial31, anti HIV32, cardiovascular 33, antiviral 
and anti cancer activity34.  
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LITERATURE REVIEW 
MANNICH BASE 
1) Antimicrobial activity: 
i) P. S. Bhasin et al.35 synthesized a series of  N-Mannich bases of 
isatin (indole-2,3-dione) and screened them for antibacterial and 
antifungal activity against 25 pathogenic bacteria and 5 pathogenic 
fungi. Most of the compounds showed moderate activity against all 
tested microbes. 
 
N
N
RR
1
NH
NH
O
NO
 
 
ii) R. P. Gupta et al.36 synthesized some mannich bases of isatin-3- 
(4’-phenyl-3’-thiosemicarbazone) and screened them for 
antibacterial activity against  E. Coli and Staphylococcus aureus. 
iii) Sridhar S.K et al.37  synthesized a series of N-mannich bases  from 
the Schiff’s bases and hydrazones of substituted isatins and 
screened them for the antibacterial activity. Mannich bases 
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exhibited higher activity than corresponding schiff bases. 
N
N
N
O
R
1
 
iv) Pandeya S. N. et al.38 synthesized Schiff base of isatin with 
pyrimethamine and its N- Mannich bases and screened them 
against 25 pathogenic bacteria and 6 pathogenic fungi. 
v) S. A. Khan et al.39 synthesized a new series of N- mannich base of 
3-semicarbazino isatin and these compounds showed remarkable 
antimicrobial activity. 
vi)  S. N. Pandeya et al.40 synthesized N- mannich bases of  
3-[N2–pyrimethaminylimino] isatin and reported them as potential 
antimicrobial agents. 
vii) Olcay Bekircan et al.41 synthesized Schiff and mannich bases of 
isatin with 4-amino-4,5-dihydro-1H-1,2,4 triazole-5-one and 
screened them for antimicrobial activity. 
N
N
O
N
N
N N
H
O
X
R
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viii) Mirjana Kupini et al.42 synthesized certain nitroisatin N-mannich 
bases and screened them for their antibacterial and antifungal 
activity. 
ix) R. P. Singh et al.43 synthesized certain mannich bases of isatin and 
screened them for their antimicrobial activity. 
R
O
NH
N
O
N
O
CH3
N
R
R
R
 
x) V. Ravichandran et al.44  synthesized certain mannich bases of 
isatin and its derivatives with 2-[(2,6-dichlorophenyl) amino] phenyl 
acetic acid and screened them for antibacterial and antifungal 
activity. Most of the compounds showed moderate antibacterial 
activity and certain compounds showed good antifungal activity. 
N
NR
O
N
Cl
Cl
OH
O
 
 
xi) Surendra et al.45 sythesised certain N-Mannich bases of 3-[N’-
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sulphadoximino]isatin and evaluated them for their antimicrobial 
activity. 
xii) S. N. Pandeya et al.46 synthesized certain mannich bases of 
isatinlyl pyrimidines and screened them for their antibacterial 
activity.  
N
N
O
N
R
2
R
1
N
N
CH3
Cl
R
 
2) As anticonvulsants 
i)    Sridhar S. K. et al.47 synthesized certain new mannich bases of 
isatin and were evaluated by maximal electroshock method (MES) 
and metrazol-induced convulsions (MET) at 30, 100 and 300 mg/kg 
dose levels. Eight compounds of the series exhibited significant 
anticonvulsant activity at 30 mg/kg dose level. 
3)   As antileishmanial agents 
i) R. S. Varma et al.48 synthesized certain mannich bases of isatin 
and were tested for antileishmanial activity. Some compounds 
showed 100% inhibition to L. donovani. 
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S
N
R
N
N
O
N
R
5
R
4
R
2
R
1
R
3
NH
 
4) Mannich bases an analgesic, anti inflammatory and antipyretic 
i) S. K. Sridhar et al.49 synthesized N- mannich bases with the phenyl 
hydrazones of isatin. Out of the synthesized compounds about  
5 compounds exhibited good activity.  
5)  As anti HIV agents 
i) S. N. Pandeya et al.50 synthesized certain mannich bases of isatin 
coupled with N-[6-chlorobenzothiazol-2-yl] thiosemicarbazide. 
These compounds were screened against HIV-1(IIIB) in MT4 cells.   
ii) S. N. Pandeya et al.51 synthesized N- mannich bases by treating 3-
(4'-pyridyl)-4-amino-5-mercapto-4-(H)-1,2,4-triazole with  Isatin 
(indole 2,3-dione) and its 5-chloro and 5-bromo derivatives to form 
Schiff bases and the N-Mannich bases and screened them for their 
anti HIV activity. 
iii) S. N. Pandeya et al.52 synthesized mannich bases from isatin 
derivatives and N-[4-(4’-chlorophenyl)thiazol-2-yl]thiosemicarbazide 
and were screened for their anti HIV activity. 
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S
N
N
N
R
2
R
1
O
N NH
NH
S
Cl
R
 
6)  As anticancer agents 
i) Yogeeshwari P. et al.53 synthesized mannich bases of isatin by 
treating them with formaldehyde and several isatin derivatives and 
these compounds were screened for their cytotoxic activity and 
some were found to be potent anticancer agent. 
7)   As antitubercular agents 
i) S. N. Pandeya et al.54 synthesized mannich bases of norfloxazin by 
treating them with formaldehyde and isatin and screened them 
against Mycobacterium tuberculosis most of the compounds 
showed promising activity. 
 
 
 
 
 
  
 
26 
 
 
 
 
 
 
 
 
 
 
 
 
PURPOSE OF WORK 
          Literature survey of quinazolinones showed these moieties to 
possess remarkable biological activities which includes antibacterial, 
analgesic, antifungal, CNS depressant activity  etc. 
          Literature review shows that mannich bases of isatin exhibit broad 
range of activity. So it was planned to synthesize mannich bases having 
both quinazolinone and isatin moiety and check their biological activity. 
          Microwave mediated synthesis have gained considerable 
importance in the organic chemistry synthesis due to the short reaction 
time compared to the conventional heating method and increased 
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percentage yield of products. The present investigation consist of the 
following sections. 
Part 1 
Taking into consideration the above findings it was considered worthwhile 
to synthesize some new isatin based mannich bases of quinazolin-4-one.  
          General structure of mannich base undertaken in present study 
a) 1- substituted methyl-3-(2-phenyl-4-oxo-3-quinazolinylimino)-1, 
 3- dihydro-indol-2-one. 
N
N
O
N
N
R
O
 
Part 2 
Spectral studies  
Structure of newly synthesized compounds were to be confirmed 
from UV, IR, PMR and mass datas. 
Part 3 
 Antimicrobial studies 
The compounds synthesized were to be screened against selected 
gram (+)ve and gram (-)ve micro organisms and activities to be compared 
against a standard antibiotic. The prepared compounds were also planned 
to be subjected to antifungal screening and the activities compared with a 
standard antifungal agent. 
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Part 4 
Antioxidant activity 
The antioxidant activity of the synthesized compounds were to be 
evaluated and compared with the standard drug (ascorbic acid) by the 
DPPH method. The percentage antioxidant activity could be calculated by 
the formula given below: 
Scavenging activity (AA %) = {[(Ab + As) – Am] / Ab} X 100% 
Ab = Absorbance of 1.5 ml DPPH solution + 1.5 ml methanol 
          Am= Absorbance of 1.5 ml DPPH solution + 1.5 ml drug solution 
          As= Absorbance of 1.5 ml drug solution + 1.5 ml methanol  
 
 
 
 
 
 
CHEMISTRY 
MANNICH BASE55-58 
The mannich base is an amine, which is formed in the reaction of 
electrophilic imine salt and enol of carbonyl compound (usually ketone or 
aldehyde).The mannich reaction is an organic reaction which consists of an 
amino alkylation of an acidic proton placed next to a carbonyl functional group 
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with formaldehyde and ammonia or any primary or secondary amine. The final 
product is an β-amino carbonyl compound also known as the mannich base. 
 
Mannich reaction enables two different molecules to be bonded together 
in one step. When an amino group is present in the substrate, intramolecular 
mannich reaction leading to cyclic compounds or to polymeric derivatives may 
occur. Hence this versatility of the mannich reaction, along with the remarkable 
possibilities of exploiting the reactivity of the mannich bases in producing further 
derivatives, makes it possible to attain the most varied chemical structures in 
conformity with the practical requirements and application needed in the industry. 
The substrates suitable for the mannich reaction are available among a 
number of different compounds, and a very few limitations are found in the choice 
of the amine reactant, except the unreactive tertiary amine derivatives. The most 
significant chemical moieties that enable mannich reaction to be performed are 
listed below.  
Substrates in the mannich reaction are in general, XH compounds having 
nucleophilic properties, with X being equal to C, N or other hetroatoms. CH 
compounds are suitably activated saturated and unsaturated derivatives and NH 
substrates may be amides, amines, hetrocycles, etc. Out of the OH substrates, 
alcohols are mainly able to give stable mannich products. Sulphur and 
phosphorus containing substrates are XH derivatives having the X atom bonded 
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to the heteroatom in lower oxidation state like thiols, sulfinic acids and 
respectively, phosphine and phosphorus acid derivatives.  
The mannich reaction is carried out on unusual substrates, characterized 
by molecules having very complex structures. 
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GENERAL CLASSIFICATION OF MANNICH DERIVATIVES ACCORDING TO 
SUBSTRATE AND AMINE TYPE. 
a) C – Mannich bases 
1. 
O
R N
 
2. 
Z N
 (where Z= carboxy, N-hetroaryl, Nitro group, etc) 
3. 
Z N
(where Z=R2C, R-N) 
4. R
N
 
5. 
OH
N
R
(or NH- activated benzene ring) 
6. 
Z
N
  (Z= N, O, etc.) hetrocycle  
 
b) N- Mannich bases 
1. 
N
R
R
N
 
2. R
N
Z
  (Z= O, S) 
3. 
Z N
N
R
R
 (hetrocycle) 
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c) O-, S- etc. Mannich bases 
1. R-O-CH2-N< 
2. R-S-CH2-N< 
3. R-SO2-CH2-N< 
COMPONENTS OF A MANNICH REACTION: 
The three important reactants in a mannich reaction are: 
a) compounds containing reactive hydrogen atom 
b) amines 
c) aldehydes 
A. THE COMPOUNDS CONTAINING REACTIVE HYDROGEN ATOM:                    
i) Ketones:  
This includes all ketones possessing –CO.CH< group. Unsymmetrical 
ketones react predominantly at the higher substituted alpha position. 
ii) Acids and their esters:  
A number of acids containing highly active hydrogen atom in the alpha 
position can be used instead of aldehydes and ketones. When an acid is 
employed, the free secondary amine, rather than the salt, is used. 
Example : 1) with ethyl malonic acid 
C2H5CH(COOH)2 + CH2O + (CH3)2NH ÆC2H5C(COOH)2.CH2N(CH3)2 
 
iii) Phenols:  
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The o- and p- hydrogens in phenols are sufficiently acidic to enter the 
mannich reaction. 
OH
CH2 O NH
CH3
CH3
OH
N CH3
CH3
N
CH3 CH3
N
CH3
CH3
2,4,6-tris[(dimethylamino)methyl]phenol
N-methylmethanamine
formaldehyde
phenol
++
 
iv) Furan, pyran, indole and their derivatives:                              
These compounds are sensitive to acids and hence the reaction must 
be carried out in the presence of a weak acid like acetic acid.  
NH CH2 O
CH3
CH3
NH
CH3
N
CH3
N
H
++
 
v) Methylated pyridines and quinazolines 
CH3N
CH2 O NH CH3
CH3
N N
CH3
CH3
+
2-methylpyridine
N,N-dimethyl-2-pyridin-2-ylethanamine  
 
 
 
vi) Nitro compounds:  
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Primary and secondary nitro compounds undergo the mannich 
reaction. 
 
             
                                                                              NO2 
 
vii) Acetylenes 
Phenyl acetylene and some of its nuclear substituted derivatives react 
readily with formaldehyde and secondary amines. 
 
 
                  In certain cases like acetophenone if the compound contains a second 
reactive hydrogen, further reaction may occur with the introduction of another –
CH2-NR2  group. 
Example: 
C6H5COCH3 + CH2O + HN(CH3)2 Æ C6H5COCH2CH2N(CH3)2 + CH2O + HN(CH3)2  
Æ C6H5COCH[CH2N(CH3)2]2 
B)  AMINES:  
The amine may be primary or secondary but the most convenient are 
secondary amines since they possess only one replaceable hydrogen. If a 
C6H5C=CH  + CH2O + (C2H5) 2 NH→C6H5C=C-CH2-N(C2H5)2 
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primary amine is used, a secondary amine is formed which further react to give 
tertiary amines. 
CH3COCH3 + CH2O + NH2CH3 Æ CH3COCH2CH2NHCH3 + CH2O + CH3COCH3 
Æ CH3N(CH2CH2COCH3)2    
   C)  ALDEHYDES:  
Formaldehyde is the most frequently used aldehyde. Higher aldehydes 
like succinaldehyde are also used in the Robinson synthesis. 
 
FURTHER REACTIONS OF MANNICH BASE: 
The mannich base obtained can further react in many ways 
a. If a primary or secondary amine is used, the mannich base may condense 
with one or two additional molecules of aldehyde and acdtive compound. 
HCHO
CH3COR
HCHO
CH3COR
H2NCH2CH2COR  HN(CH2CH2COR)2 N(CH2CH2COR)3 
 
b. If the active hydrogen compound has two or three active hydrogens, the 
mannich base may condense with one or two additional molecules of 
aldehyde and ammonia or amine. 
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E.g. 
H2NCH2CH2COR  →(H2NCH2)2HCOR→(H2NCH2)3COR 
c. Sometimes mannich base may react with excess of formaldehyde. 
H2NCH2CH2COR + HCHO            H2C=NCH2CH2COR 
 
APPLICATIONS OF MANNICH BASES:  
a) Mannich base as an intermediate in synthesis: 
i) In the conversion of ketone to its next higher homologue: 
Reduction of the unsaturated ketone obtained by the decomposition of a 
mannich base leads to a ketone with one more methylene group than that used in 
the preparation of the mannich base. 
CH3O
CH2O + HN(CH3)2
(Mannich reaction)
O N
CH3
CH3
Δ
O
CH2
Ni/H2
O
CH3
1-phenylethanone
3-(dimethylamino)-1-phenylpropan-1-one
1-phenylpropan-1-one
1-phenylprop-2-en-1-one
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ii) In building the ring systems for steroids(Robinson’s ring 
 extension): 
CH3
O
+ CH3
CH2
O CH3
O
CH3
O
-H2O
CH3
O
2-methylcyclohexanone
poly[2-methyl-2-(3-oxobutyl)cyclohexanone]
4a-methyl-4,4a,5,6,7,8-hexahydronaphthalen-2(3H)-one
C2H5O
-
 
b) Synthesis of natural products: 
i) Synthesis of atropine( Robinson’s synthesis ): 
  
ii) Synthesis of quinine: 
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In the synthesis of quinine the introduction of the methyl group into the 8th 
position of the 7- hydroxyisoquinoline was done through mannich reaction. 
Reduction of the 8-methyl derivative was brought about by sodium 
methoxide at high temperature (hydride-ion transfer). 
N
OH N
H
N
OH
N
N
CH3
OH
+ CH2O +
H
O
-
200
0
C
H+
-H2O
8-methylisoquinolin-7-ol
isoquinolin-7-ol
 
 
iii) From Gramine (Mannich base of indole): 
a) Synthesis of heteroauxin: 
Gramine on methylation with dimethylsulphate followed by the treatment 
with cyanide ion and then hydrolysis gives Heteroauxin. 
N
H
N
CH3
CH3
1-(1H-indol-3-yl)-N,N-dimethylmethanamine
(CH3)2SO4
N
H
N
+
CH3
CH3
CH3
CN-
OH- N
H
COOH
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b) Synthesis of tryptophan: 
N
H
N
CH3
CH3
1-(1H-indol-3-yl)-N,N-dimethylmethanamine
(CH3)2SO4
N
H
N
+
CH3
CH3
CH3
N
H
COOH
NH2
CH3CONH-C(CO2Et)2-(CH3)3N
N
H
CO2Et
NH
CH3
O
EtO2C
OH-
H+
 
c) Synthesis of medicinal compounds: 
i) Local anaesthetic (tutocaine): 
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CH3
CH3
O
+ CH2O + NH CH3
CH3
CH3
CH3
N
CH3
CH3
O
-H2O
OH
CH3 N
CH3
CH3
CH3COO
CH3 CH3
N
CH3
CH3
tutocaine
butan-2-one 4-(dimethylamino)-3-methylbutan-2-one
4-(dimethylamino)-3-methylbutan-2-ol
 
 
MECHANISMS INVOLVED IN THE FORMATION OF MANNICH BASE: 
Mannich reaction: 
It is a reaction in which compounds having active hydrogen react 
with non-enolizable aldehydes and ammonia or primary or secondary 
amines to give aminomethylated products /mannich bases. 
MECHANISM INVOLVED: 
Acid catalyzed reaction: 
STEP I 
The lone pair of electrons on the nitrogen atom of the amine attacks the 
carbonyl group of the formaldehyde in the presence of acid to give an adduct, 
which eliminate water to form electrophile. 
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STEP II 
The acid catalyses the conversion of acetone to its enolic tautomer 
 
STEP III 
The enol then reacts with the electrophile and the resulting adduct loses a 
proton to form mannich base. 
 
 
 
BASE CATALYSED REACTION: 
STEP I 
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The lone pair of electrons on nitrogen atom of the amine attacks the 
carbonyl carbon of formaldehyde to form an adduct. 
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STEP II 
Base catalyses the conversion of acetone to carbanion and the carbanion 
reacts with the adduct to form the mannich base with the elimination of hydroxide 
ion. 
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SYNTHETIC AND ANALYTICAL WORKS 
1. MATERIALS AND METHODS USED 
All the amines used were obtained from Hi-media and Loba chem. 
The solvents and chemicals were procured from S.D Fine chem. Ltd., 
Fisher inorganics Ltd. All the compounds procured were purified and dried 
whenever necessary before use, following the standard methods. 
Melting points were determined by using melting point apparatus, 
MR-VIS, Visual Melting Range Apparatus, Lab India. Purity of the 
compounds was routinely checked by TLC using plates coated with silica 
gel – G. Iodine vapours were used as the visualizing agents. Microwave 
synthesis was carried out using DAEWOO KOG-370A at Pharmaceutical 
Chemistry Laboratory, College of Pharmacy, SRIPMS, Coimbatore. 
UV spectras were recorded on JASCO – V – 530. IR spectras were 
recorded on JASCO FT/IR – 410 at the Pharmaceutical Analytical 
Laboratory, College of Pharmacy, SRIPMS, Coimbatore. 
Mass spectra and the PMR spectra were recorded at QUEST 
Research and Training Institute, Bangalore. 
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2. SCHEME 
SCHEME – I 
(CONVENTIONAL METHOD) 
 
OH
NH2
O
+
COCl
benzoyl chloride2-aminobenzoic acid
O
N
O
NH2 NH2
+
N
N
O
NH2
N
N
O
Ph
N
N
R
O
N
H
O
O
ethanol
ethanol
N
N
O
Ph
N
N
H
O
Schiff base(3)
Mannich base 4 (a-k)
3-amino-2-phenylquinazol-4-one (2)
2-phenyl-3,1-benzoxazin-4-one (I)
GAA
+
 
SCHEME II 
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(MICROWAVE SYNTHESIS) 
 
OH
NH2
O
2-aminobenzoic acid
O
N
O
NH2 NH2
+
N
N
O
NH2
N
N
O
Ph
N
N
R
O
N
H
O
O
ethanol
ethanol
N
N
O
Ph
N
N
H
O
Schiff base(3)
Mannich base 4 (a-k)
GAA
M.W.I at 80% power, 3 min
DMF
HCHO
Amines
M.W.I at 80% power, 3 min
3hr, reflux
PhCOCl
M. W. I at 80% power,
10min
2-phenyl-3,1-benzoxazin-4-one (I)
Isatin
3-amino-2-phenylquinazol-4-one (2)
 
 
TABLE No.  1 :  AMINES 
AMINES COMPOUND CODE R 
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Piperidine 4 (a) N  
Morpholine 4(b) N O 
N-Methyl Aniline 4(c) 
N
H3C
 
N-methylpiperazine 4(d) N N CH3 
Dimethylamine 4(e) -N(CH3)2 
Diethylamine 4(f) -N(C2H5)2 
Dipropylamine 4(g) -N(C3H7)2 
4- chloroaniline 4(h) 
NH Cl
 
4- bromoaniline 4(i) NH Br
 
4-fluoroaniline 4(j) NH F
 
Aniline 4(k) NH
 
 
3. SYNTHETIC WORK 
SCHEME I (CONVENTIONAL METHOD) 
Step I 
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Synthesis of 2–phenyl–3,1–benzoxazin-4–one (1):59 
To the solution of anthranilic acid (13.714g, 0.1 mol) dissolved in 
pyridine (60ml), benzoyl chloride (23.462g, 0.2mol) was added. The 
mixture was stirred for 30min followed by the treatment with 5% NaHCO3 
(15ml). The separated solid was recrystallised from ethanol, m.p.1200C. 
The purity of the compounds was determined by single spot on the 
TLC plates. The solvent system used was chloroform: methanol (7:3). 
Step II 
Synthesis of 3-amino-2-phenylquinazolin-4-one (2):59 
A mixture of 2–phenyl–3,1–benzoxazin-4–one (11.15g, 0.05mol) 
and hydrazine hydrate (2.454g, 0.05mol) in ethanol was refluxed for 3 h 
and cooled. The separated solid was washed and recrystallised from 
ethanol (85%), m. p. 192-1940C.  
The purity of the compounds was determined by single spot on the 
TLC plates. The solvent system used was chloroform. 
 
 
 
Step III 
Synthesis of Schiff base (3):60 
A mixture of 2 (2.13, 0.01mol) and isatin (1.441g, 0.01mol) in 10ml 
of ethanol and few drops of glacial acetic acid was refluxed for 1 h. The 
reaction mixture was kept at room temperature overnight. The yellow solid 
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thus separated out was washed with methanol and recrystallised from 
methanol, m. p. 270.20C . 
The purity of the compounds was determined by single spot on the 
TLC plates. The solvent system used was chloroform: methanol (7:3). 
 
Step IV 
Synthesis of Mannich base (4):60 
A mixture of 3 (Schiff base)(7.02g, 0.02mol) was dissolved in 
minimum quantity of DMF and slightly more amount of formaldehyde 
(0.02mol) and a primary or secondary amine (0.025) was added and 
stirred vigorously and heated on a water bath for 1 h and cooled and the 
product was washed and dried and recrystallised from methanol – dioxan 
mixture. 
The purity of the compounds was determined by single spot on the 
TLC plates. The solvent system used was chloroform: methanol (7:3). 
 
SCHEME II (MICROWAVE METHOD) 
Step I 
Synthesis of 2–phenyl–3,1–benzoxazin-4–one (1):61 
To anthranilic acid (13.714, 0.1 mol), benzoyl chloride (23.462ml, 
0.2mol) was added. The mixture was irradiated for 10min at 80% power, 
the solid so formed was washed with 5% NaHCO3 (15ml). The separated 
solid was recrystallised from ethanol, m. p. 1200C. 
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The purity of the compounds was determined by single spot on the 
TLC plates. The solvent system used was chloroform: methanol (7:3). 
 
Step III 
Synthesis of Schiff’s base (3):62 
A mixture of 2 (2.13, 0.01mol) and isatin (1.441g, 0.01mol) in 
ethanol and glacial acetic acid was irradiated at 80% power for 3min. The 
yellow solid thus separated out was washed with methanol and 
recrystallised from methanol, m. p.2720C  
The purity of the compounds was determined by single spot on the 
TLC plates. The solvent system used was chloroform: methanol (7:3). 
 
 
 
Step IV 
Synthesis of mannich base (4):62 
A mixture of 3 (Schiff base)(7.02g, 0.02mol) was dissolved in 
minimum quantity of DMF and slightly more amount of formaldehyde 
(0.02mol) and a primary or secondary amine (0.025) was added, this was 
then irradiated for 3min at 80% power and kept overnight. The product 
formed was washed in cold methanol, dried and recrystallised from 
methanol – dioxan mixture. 
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The purity of the compounds was determined by single spot on the 
TLC plates. The solvent system used was chloroform: methanol (7:3). 
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TABLE No.  2 :  CHARACTERIZATION DATA OF COMPOUNDS 4 (a-d)  
% Yield Reaction Time d 
e R 
Molecular 
Formula Mol.Wt Conventional MW Conventional (h) 
MW 
(min) 
Melting
Point 
(°C) 
N
 
C29H27N5O2 477 72 89 1 3 251 
N O
 
C28H25N5O3 479 69 86 1 3 248 
N
H3C
 
 
C30H24N5O2 499 67 82 1 3 263 
 
N N CH3
 
 
C29H28N6O2 492 65 79 1 3 255 
*Solvent system - chloroform: methanol (7:3)
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 CHARACTERIZATION DATA OF COMPOUNDS 4 (e-h) 
 
% Yield Reaction Time d 
e R 
Molecular 
Formula 
Mol 
Wt Conventional MW Conventional(h) MW (min) 
Melting
Point 
(°C) 
-N(CH3)2 C25H21N5O2 423 62 75 1 3 292
-N(C2H5)2 
 C27H25N5O2 452 70 76 1 3 179
-N(C3H7)2 C29H29N5O2 480 65 83 1 3 257
 
NH Cl
 
 
C29H20ClN5O2 521 65 77 1 3 286
*Solvent system - chloroform: methanol (7:3) 
 
 
CHARACTERIZATION DATA OF COMPOUNDS 4 (i-k) 
 
% Yield Reaction time d R Molecular Formula 
Mol. 
Wt 
Conventional MW Conventional (h) MW (min) 
Melti
Poin
(°C
NH Br
 
C29H20BrN5O2 566 64 77 1 3 268
NH F
 
C29H20FN5O2 505 60 74 1 3 210
NH
 
C29H21N5O2 471 65 77 1 3 286
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*Solvent system - chloroform: methanol (7:3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. SPECTRAL CHARACTERIZATION STUDIES 
Spectral data of prototype compounds 
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     Structures of the mannich bases synthesized were established on 
the basis of chemical data, UV, IR, NMR and Mass spectral data. The 
purity of the compounds were established by single spot on TLC plate. 
Compound – I  :  4 k 
NN
O
N
N
NH
O
 
Chemical name                 :   1-phenylamino-methyl-3-(2-phenyl-4-oxo-3-  
quinazolinylimino)-1,3-dihydro-indole-2-one 
Molecular formula              :  C29H21N5O2 
Molecular weight  : 471.5 
Rf value  :  0.67 
Percentage yield                 : 65% (Conventional method)                                                        
77% (Microwave method) 
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a) UV Spectrum 
Solvent           :   methanol 
 λmax                        :   310nm 
b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[TABLE NO.:3] 
S. No. Type of Vibration Wave No (cm-1) 
1. NH Stretch 3220.54 
2. Aliphatic CH Stretch 2926.45 
3. C=O of Isatin  1725.01 
4. C=O of Quinazolinone 1680.63 
5. C=N Stretch 1526.38 
6. C-N Stretch 1349.93 
 
c) PMR Spectrum (DMSO d6): 
The Proton Magnetic resonance spectrum of the compound was in 
full agreement with the compounds molecular formula, with regard to 
proton count and also chemical shift.[TABLE NO. :4] 
S. No δ Values (ppm) Type of protons No of protons 
1. 4.8 N- CH2-N 2 
2. 6.88-7.27 Aromatic protons and NH protons 19 
 
 
d) Mass Spectrum 
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(i) Molecular ion peak i. e., (M+1)+ peak at 472. 
NN N
O
N
O
NH
 
 Different fragment ions  are there. 
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UV SPECTRUM OF COMPOUND 4 k 
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IR SPECTRUM 4 k 
 
PMR SPECTRUM OF 4 k 
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MASS SPECTRUM OF  4 k 
Chapter 5 Synthetic & Analytical Work 
 
 56 
Compound – II  :  4 a 
NN
O
N N
N
O
 
Chemical name            :  1-Piperidino-methyl-3-(2-phenyl-4-oxo-3-
quinazolinylimino)-1,3-dihydro-indole-2-
one  
Molecular formula                    : C28H25N5O2 
a) UV Spectrum 
Solvent          :   methanol 
λmax                        :   314nm 
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b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[TABLE NO.: 5] 
S. No. Type of Vibration Wave No (cm-1) 
1. Aromatic C-H Stretch 3110.36 
2. Aliphatic CH Stretch 2912.30 
3. C=O of Quinazolinone 1655.78 
4. C=N Stretch 1574.27 
5. C-N Stretch 1340.96 
6. Aromatic C-H bend 707.74 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 5 Synthetic & Analytical Work 
 58 
Compound – III  :  4 b 
N
N
O
N
N N
O
O
 
Chemical name       :    1-Morpholino-methyl-3-(2-phenyl-4-oxo-3-
quinazolinylimino)-1,3-dihydro-indole-2-
one 
Molecular formula              :   C28H25N5O3 
a) UV Spectrum 
   Solvent          :   methanol 
   λmax                        :   308nm 
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b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[TABLE NO.: 6] 
S.No. Type of Vibration Wave No (cm-1) 
1. Aromatic CH Stretch 3082.65 
2. Aliphatic CH Stretch 2971.77 
3. C=O of Quinazolinone 1651.73 
4. C=N Stretch 1522.52 
5. C-N Stretch 1343.18 
6. C-H Bend 698.105 
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Compound – IV  :  4 c 
NN
O
N
N
N
O CH3
 
Chemical name  :  1-(N-methylphenylamino)-methyl-3-(2-phenyl-4-
oxo-3-quinazolinylimino)-1,3-dihydro-indole-2-
one 
Molecular formula  :  C30H23N5O2 
a) UV Spectrum 
   Solvent           :       Methanol 
   λmax                          :        313nm 
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b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[TABLE NO.: 7] 
S.No. Type of Vibration Wave No (cm-1) 
1. C=O of Quinazolinone 1673.91 
2. C=N Stretch 1589.06 
3. C-N Stretch 1347.03 
5. C-H Bend 698.10 
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Compound – V  :  4 d 
NN
O
N
N
O
N N CH3
 
Chemical name                :  1-(N-methylpiperazino)-methyl-3-(2-phenyl-
4-oxo-3-quinazolinylimino)-1,3-dihydro-
indole-2-one  
Molecular formula             :  C28H26N6O2 
a) UV Spectrum 
Solvent           :    methanol 
   λmax                         :    307nm 
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b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[TABLE NO. :8] 
S.No. Type of Vibration Wave No (cm-1) 
1. Aromatic C-H Stretch 3102.9 
2. Aliphatic CH Stretch 2926.45 
3. C=O of Quinazolinone 1680.66 
4. C=N Stretch 1526.38 
5. C-N Stretch 1349.93 
6. Aromatic C-H bend 709.676 
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Compound – VI  :  4 e 
NN
O
N
N
O
N
CH3
CH3
 
Chemical name             :   1-(N,N-dimethylamino)- methyl-3-(2-phenyl-4-
oxo-3-quinazolinylimino)-1,3-dihydro-indole-2-
one  
Molecular formula :  C25H21N5O2 
a) UV Spectrum 
 Solvent           :    methanol 
   λmax                         :    311nm 
 
 
 
 
 
 
 
 
b) Infrared spectrum: 
Chapter 5 Synthetic & Analytical Work 
 
 65 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[TABLE NO.:9] 
S.No. Type of Vibration Wave No (cm-1) 
1. Aromatic CH Stretch 3078.8 
2. C=N Stretch 1441.31 
3. C-N Stretch 1346.07 
4. Aromatic CH Bend 696.177 
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Compound – VII  :  4 f 
CH3
NN
O
N
N
O
N
CH3  
Chemical name   : 1-(N,N-diethylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one  
Molecular formula  :  C27H25N5O2 
a) UV Spectrum 
Solvent           :    methanol 
 λmax                         :    317nm 
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b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[ TABLE NO.:10] 
S. No. Type of Vibration Wave No (cm-1) 
1. Aromatic CH Stretch 3146.29 
2. C=O of Isatin 1756.83 
3. C=O of Quinazolinone 1657.52 
4. C=N Stretch 1439.6 
5. C-N Stretch 1340.28 
6. Aromatic CH Bend 696.177 
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Compound – VIII  :  4 g 
NN
O
N
N
O
NCH3
CH3  
Chemical name    : 1-(N,N-di-n-propylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
Molecular formula              :   C29H29N5O2 
a) UV Spectrum 
Solvent            :    methanol 
λmax                         :    305nm 
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b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[ TABLE NO.:11] 
S.No. Type of Vibration Wave No (cm-1) 
1. Aromatic CH Stretch 3157.86 
2. Aliphatic CH Stretch 2945.73 
3. C=O of Isatin 1722.12 
4. C=N Stretch 1441.53 
5. C-N Stretch 1343.18 
7. Aromatic CH Bend 702.926 
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Compound – IX  :  4 h 
NN
O
N
N
O
NH
Cl
 
Chemical name             :   1-(4-Chlorophenylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
Molecular formula :  C29H20ClN5O2 
a) UV Spectrum 
Solvent :   methanol 
 λmax                       :    305nm 
b) 
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Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[ TABLE NO.:12] 
S.No. Type of Vibration Wave No (cm-1) 
1. NH Stretch 3264.89 
2. Aliphatic CH Stretch 2942.84 
3. C=O of Quinazolinone 1666.2 
4. C=N Stretch 1443.46 
5. C-N Stretch 1352.26 
6. Aromatic CH Bend 702.926 
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Compound – X  :  4 i 
NN
O
N
N
O
NH
Br
 
Chemical name                :  1-(4-Bromophenylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
Molecular formula           : C29H20BrN5O2 
a) UV Spectrum 
Solvent           :    methanol 
λmax                         : 305nm 
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b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[ TABLE NO.:13] 
S.No. Type of Vibration Wave No (cm-1) 
1. NH Stretch 3234.13 
2. Aromatic CH Stretch 3171.36 
3. Aliphatic CH Stretch 2885.95 
4. C=O of Isatin 1736.58 
5. C=N Stretch 1442.49 
6. C-N Stretch 1350.89 
7. Aromatic CH Bend 701.962 
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Compound – XI  :  4 j 
NN
O
N
N
O
NH
F
 
Chemical name              : 1-(4-Flurophenylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
Molecular formula :  C29H20FN5O2 
a) UV Spectrum 
Solvent            :   Methanol 
 λmax                          :    305nm 
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b) Infrared spectrum: 
The IR spectrum of the above compound showed characteristic 
absorption bands in the following region.[ TABLE NO.:14] 
S.No. Type of Vibration Wave No (cm-1) 
1. NH Stretch 3230.18 
2. Aromatic CH Stretch 3186.79 
3. C=O of Isatin 1777.08 
4. C=N Stretch 1442.49 
5. C-N Stretch 1349.93 
6. Aromatic CH Bend 703.89 
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ANTIMICROBIAL SCREENING 
APPARATUS AND CHEMICALS REQUIRED 
Sterile discs   :  Hi Media 
Standard discs of drugs :  Hi Media 
Sterile swab   :  Hi Media 
Non- absorbent cotton :  Rama Raju Surgical cotton Ltd. 
Conical flask (250 ml) :  Borosil 
Test Tubes   :  Borosil 
Petri dishes   :  SD Fine - Chem Ltd. 
Micropipettes  :  VARI pipettes (Hi- Tab Lab) 
Hot air oven   :  Technico Equipments 
Autoclave   :  Universal Autoclave 
Laminar Flow Unit   :  CLEAN AIR Instruments Inc. 
Incubator   :  Technico Incubator 
Micro tips   :  Tarsons 
 
 The antibacterial and antifungal screening were carried out in the 
Pharmaceutical Biotechnology Laboratory, College of Pharmacy, SRIPMS, 
Coimbatore. 
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SCREENING FOR ANTIBACTERIAL ACTIVITY64,65 
Media: Mueller- Hinton agar 
 Mueller Hinton broth gelled by the addition of 2% agar of 
bacteriological grade. 
Ingredients 
Casein enzymic hydrolysate :    17.5 gL-1 
Beef infusion    :     300 gL-1 
Soluble starch   :     1.5 gL-1 
Final pH at 250C                      :    7.4 ± 0.2 
Preparation 
 The ingredients were dissolved in distilled water with the aid of heat 
and pH was adjusted to 7.2 - 7.6 using dilute alkali or acid. 
Sterilization 
 15-30 ml of Mueller Hinton agar was transferred to petriplate and 
sealed. It was then autoclaved at a pressure of 15 psi (121oC) for not less 
than 15 minutes. 
Organisms used 
 Staphylococcus aureus NCIM 5021, Bacillus subtilis NCIM 2010, 
Pseudomonas aeruginosa NCIM 5029 and Escherichia coli NCIM 2911 
were procured from National Chemical Laboratory, Pune and stored in the 
Pharmaceutical Biotechnology Laboratory, College of Pharmacy, SRIPMS, 
Coimbatore-44. The strains were confirmed for their purity and identity by 
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Gram’s staining method and their characteristic biochemical reactions. The 
selected strains were preserved by subculturing them periodically on 
nutrient agar slants and storing them under frozen conditions. For the 
study, fresh 24 h broth cultures were used after standardization of the 
culture. 
Working conditions 
 The entire work was done using vertical laminar flow hood so as to 
provide aseptic conditions. Before commencement of the work, air 
sampling was carried out using a sterile nutrient agar plate and exposing it 
to the environment inside the hood. After incubation it was checked for the 
growth of microorganism and absence of growth confirmed aseptic 
working conditions. 
Preparation of inoculum   
 The inoculum for the experiment was prepared fresh in Mueller 
Hinton broth from preserved frozen slants. It was incubated at 37oC for 18-
24 hrs and used after standardization. 
Drugs used  : quinazolinyl mannich base 
Standard used :  Ciprofloxacin (5mcg/disc) 
Vehicle used  :  Dimethyl sulphoxide 
 
ANTIBACTERIAL SCREENING  
 Mueller Hinton agar plates were prepared aseptically to get a 
thickness of 5-6 mm. The plates were allowed to solidify and inverted to 
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prevent the condensate falling on the agar surface. The plates were dried 
at 37oC before inoculation.  
 The organisms Staphylococcus aureus NCIM 5021, Bacillus subtilis 
NCIM 2010, Pseudomonas aeruginosa NCIM 5029 and Escherichia coli 
NCIM 2911  were inoculated in the plates prepared earlier, by dipping a 
sterile swab in the previously standardized inoculum, removing the excess 
of inoculum by pressing and rotating the swab firmly against the sides of 
the culture tube above the level of the liquid and finally streaking the swab 
all over the surface of the medium 3 times, rotating the plates through an 
angle of 60o after each application. Finally the swab was pressed round 
the edge of the agar surface. It was allowed to dry at room temperature, 
with the lid closed. The sterile disc containing test drugs, standard and 
blank were placed on the previously inoculated surface of the Mueller 
Hinton agar plate and it was kept in the refrigerator for one hour to 
facilitate uniform diffusion of the drug. 
 Petriplates were prepared and they were then incubated for 18-24 
h. Observations were made for zone of inhibition around the discs and 
compared with that of standard. All the compounds synthesized were 
tested for antibacterial activity against gram-positive and gram-negative 
bacteria. Saturated solutions (100µg/disc) of the compounds were  studied 
for activity. 
ANTIBACTERIAL SCREENING 
Microorganism used as  
Gram +ve bacteria     :   Staphylococcus aureus, Bacillus subtilis 
 
Microorganism used as 
Gram -ve bacteria  :   Escherichia coli, Pseudomonas 
aeruginosa 
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Vehicle used                         :  Dimethylsulphoxide    [TABLE NO.:15] 
Diameter of Zone of Inhibition (in mm) 
Bacillus 
subtilis 
NCIM 2010 
Staphylococcus 
aureus 
NCIM 5021 
Escherichia coli 
NCIM 2911 
Pseudomonas 
aeruginosa 
NCIM 5029 
S.No Compound Code 
100µg/disc 100µg/disc 100µg/disc 100µg/disc 
1 4 a - - - - 
2 4 b - 10 - - 
3 4 c - - - - 
4 4 d 10 - - - 
5 4 e - - - - 
6 4 f <10 - - - 
7 4 g 10 - - - 
8 4 h - - - - 
9 4 i - - - - 
10 4 j - - - - 
11 4 k - - - - 
12 
Standard   
(Ciproflox
acin)  
5 
mcg/disc 
31 30 29 32 
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Figure A showing the antibacterial activity of quinazolinyl mannich 
base against Bacillus Subtilis at 100µg/disc (saturated solution) 
 
                           
 
 
 
Figure B showing the antibacterial activity of quinazolinyl mannich 
base against Staphylococcus aureus at 100µg/disc(saturated 
solution) 
 
 
 
 
SCREENING FOR ANTIFUNGAL ACTIVITY 
Media : Sabouraud Dextrose Agar 
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Ingredients  
Mycological peptone :    10 g 
Dextrose   :    40 g 
Agar    :    15 g 
Final pH at 250C         :    5.4 ± 0.2 
Water to make 1000 ml 
Preparation 
 65 g of Sabouraud dextrose agar was suspended in 1000 ml of 
distilled water and boiled to dissolve the medium completely. 
Sterilization 
 15-30 ml of Sabouraud dextrose agar was transferred to petriplate 
and sealed. It was then autoclaved at a pressure of 15 psi (121oC) for not 
less than15 minutes. 
Organism used 
 Candida albicans NCIM 3100 and Aspergillus niger NCIM 545 were 
procured from National Chemical Laboratory, Pune and stored in the 
Pharmaceutical Biotechnology Laboratory, College of Pharmacy, SRIPMS, 
Coimbatore. 
Drugs used  : Quinazolinyl mannich base 
Standard used :  Fluconazole (25mcg/disc) 
Vehicle used  :  Dimethyl sulphoxide 
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ANTIFUNGAL SCREENING 
 Sabouraud dextrose agar plates were prepared aseptically to get a 
thickness of 5-6 mm. The plates were allowed to solidify and inverted to 
prevent the condensate falling on the agar surface. The plates were dried 
at 25oC just before inoculation. 
 The organisms (Candida albicans NCIM 3100 and Aspergillus niger 
NCIM 545) were inoculated in the plates prepared earlier by dipping sterile 
swab in the inoculum, removing the excess of inoculum by pressing and 
rotating the swab firmly against the sides of the culture tube above the 
level of the liquid and finally streaking a swab all over the surface of the 
medium three times, rotating the plates through the angle of 60o after each 
application. Finally the swab was pressed round the edges of the agar 
surface. It was left to dry at room temperature with the lid closed. Sterile 
discs containing the test, standard and blank were placed in the petridish 
aseptically. Saturated solutions of the test samples were used. 
 Petriplates were prepared and they were incubated at 25oC for  
24-48 h, after placing them in the refrigerator for one hour to facilitate 
uniform diffusion. Observations were made for the zone of inhibition 
around the discs and compared with that of Fluconazole, the standard. All 
the compounds were tested for antifungal activity. 
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RESULT AND DISCUSSION OF ANTIMICROBIAL STUDIES 
Anti-bacterial studies 
           All the newly synthesized compounds were screened for anti-
bacterial activity. 
Gram- positive organism used:  
• Staphylococcus aureus NCIM 5021, 
•  Bacillus Subtilis NCIM 2010. 
Gram-negative organism used: 
• Escherichia coli NCIM 2911,  
• Pseudomonas aeruginosa NCIM 3100. 
Concentrations of 100 µg/disc (saturated solution) were used for all the 
test compounds and the results were compared with the standard drug 
Ciprofloxacin at 5µg/disc, against Gram positive and Gram negative 
bacteria using dimethyl sulphoxide (DMSO) as vehicle. 
Among the synthesized compounds, 4d (N- methyl piperazinyl 
derivative), 4g (N, N- dipropyl amino derivative) at 1000µg/disc 
concentration was found to show mild activity against B.subtilis. 
The compound 4b (morpholinyl derivative) at 100 µg/disc 
concentration was found to show mild activity against S. aureus.  
None of the compounds showed activity against P. aeruginosa and E. 
coli. Anti-bacterial activities exhibited by the synthesised compounds were 
not comparable to the standard drug Ciprofloxacin. 
 
Antifungal studies 
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All newly synthesized mannich bases of isatin were screened for 
antifungal activity against Candida albicans NCIM 3100 and Aspergillus 
niger NCIM 545 using Fluconazole (25 µg/disc) as standard and 
Dimethylsulphoxide (DMSO) as the vehicle. Concentrations of 100 µg/disc 
(saturated solution) of synthesized compounds were used for evaluating 
all the test compounds. All the compounds were found to be inactive 
against both the organisms. 
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ANTIOXIDANT STUDIES 
FREE RADICAL SCAVENGING ACTIVITY BY DPPH ASSAY METHOD 
Chemicals used 
¾ 2,2-Diphenyl-1-Picrylhydrazyl(DPPH) 
¾ Methanol 
¾ Ascorbic acid  
Preparation of solutions  
          Free radical scavenging activity of the test compounds were 
determined by DPPH assay method and compared with ascorbic acid as 
standard. 
¾ Preparation of 0.2 mM drug solution  
Weight equivalent to 0.2 mM was taken in 10 ml standard flasks 
made up to the mark with methanol and suitably diluted to get 0.2 
mM concentration. 
¾ Preparation of 0.2 mM DPPH solution  
0.008 g of DPPH was taken in a 100 ml standard flask, dissolved in 
methanol. 1ml of the above solution was taken and  diluted in 10ml 
standard flask with methanol to get a concentration of 0.2mM. 
¾ Preparation of 0.2 mM standard solution  
0.035g of ascorbic acid was taken in 100 ml standard flask, 
dissolved in methanol and the volume was adjusted to 100ml with 
methanol. 1ml of the above solution was taken in a 10ml standard 
flask and the volume was made up with methanol. 
 
 
¾ Procedure for evaluation of antioxidant activity 
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1.5 ml of 0.2 mM of DPPH solution was added to 1.5 ml of 0.2mM 
concentration of the drug solutions.  Another series of solutions 
were prepared by taking 1.5 ml of different concentrations of drug 
solutions and 1.5 ml of methanol. The above solutions were allowed 
to react at room temperature for 30 min. After 30 minutes the 
absorbance values were measured at 517 nm and percentage of 
scavenging activity was calculated using  the  following  formula  : 
Scavenging activity (%)   = [ ( Ab + As ) – Am / Ab ] X 100  
          Ab = Absorbance of 1.5 ml DPPH solution + 1.5 ml methanol 
          Am= Absorbance of 1.5 ml DPPH solution + 1.5 ml drug solution 
          As= Absorbance of 1.5 ml drug solution + 1.5 ml methanol  
 Experiments were carried out in triplicate. 
 
 
 
 
 
 
 
 
DPPH Free Radical Scavenging Activity of Test Compounds [TABLE 
NO.:16] 
 
S. 
 
Compound 
 
Trial 
Absorbance Free radical scavenging activity (%) 
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No. Code No. 
Am As Ab Scavenging activity (%) 
aScavenging 
activity(%) 
1 0.614 0.171 64 
2 0.527 0.088 66 1. 4 a 
3 0.628 0.084 54 
61±6.42 
1 0.687 0.106 53 
2 0.702 0.109 54 2. 4 b 
3 0.695 0.110 53 
53±0.58 
1 0.473 0.088 69 
2 0.493 0.172 75 3. 4 c 
3 0.489 0.168 74 
73±3.21 
1 0.786 0.314 
 
62 
2 0.814 0.308 61 4. 4 d 
3 0.820 0.308 
1.240 
 58 
64±2.08 
1 0.735 0.344 68 
2 0.688 0.342 
1.290 
 73 5. 4 e 
3 0.740 0.348 68 
70±2.89 
1 0.893 0.267 
1.235 
50 
2 0.880 0.264 52 6. 4 f 
3 0.887 0.269 
 
50 
51±1.16 
 
 
1 1.531 0.697 33 
2 1.527 0.684 35 7. 4 g 
3 1.526 0.685 32 
33±1.53 
1 1.145 0.063 13 8. 4 h 
2 1.146 0.062 
 
16 
13±2.52 
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  3 1.146 0.068 11  
1 0.987 0.112 29 
2 0.985 0.123 33 9. 4 i 
3 0.980 0.124 30 
31±2.08 
1 0.884 0.211 45 
2 0.888 0.214 48 10. 4 j 
3 0.887 0.219 
 
46 
46±1.53 
Free radical scavenging activity of the standard, Ascorbic acid= 97±0.35% 
a Results are mean ± standard deviation (S. D) 
  90 
RESULTS AND DISCUSSION 
          From the results of antioxidant activity screening of the newly 
synthesized compounds, it was found that 4c (N-methyl aniline derivative) 
exhibited the maximum free radical scavenging activity of 73% at the final 
concentration of 0.2mM. 
          Among the tested compounds 4a (piperidinyl derivative), 4b  
( morpholinyl derivative), 4d ( N-methly piperazinyl derivative), 4e ( N, N- 
dimethyl amino derivative), 4f ( N, N-diethyl amino derivative), 4j (4- 
fluorophenyl amino derivative) showed free radical scavenging activity in 
the range 40-70%, while the rest of the compounds showed less than 40% 
free radical scavenging activity. 
         Ascorbic acid which was used as the standard in this screening 
showed free radical scavenging activity of 97% at 0.1mM concentration. 
        None of the compounds exhibited superior activity compared to the 
standard ascorbic acid. 
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SUMMARY AND CONCLUSION 
SUMMARY 
Synthesis of 1-substituted-methyl-3-(2-phenyl-4-oxo-3-
quinazolinylimino)-1, 3-dihydro-indole-2-one  4(a-k) 
 
In this scheme eleven different isatin based mannich bases of quinazolin-
4-one were synthesized by four step process. 
¾ First step was the synthesis of 2- phenyl benzoxazin-4-one. 
¾ In the second step the benzoxazin-4-one was converted to  
3-amino-2-phenylquinazol-4-one by treating with hydrazine hydrate using 
ethanol as the solvent. 
¾ In the third step, Schiff’s base was synthesized by the condensation of the 
keto group of isatin with 3-amino-2-phenylquinazol-4-one. 
¾ In the fourth step, N- Mannich bases of the above Sciff’s base were 
synthesized by the reaction of amino group of isatin with formaldehyde 
and various primary and secondary amines. 
Yield of most of the derivatives by the conventional method (reaction time: 
1 hour) ranged from 60-72% and in the microwave method (reaction time: 3 min) 
ranged between 75-89%. Structures of the compounds were confirmed by UV, 
IR, PMR and Mass spectral datas. 
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 BIOLOGICAL ACTIVITY SCREENING 
Mannich bases of isatin are known to possess wide variety of biological 
activity. Hence the newly synthesized compounds were screened for 
antimicrobial and antioxidant activity. 
ANTIBACTERIAL STUDIES 
• Saturated concentration(100µg/disc) of all the test compounds were used 
and the results were compared with that of the standard Ciprofloxacin at 5 
mcg/disc concentration, against Gram positive and Gram negative 
bacteria using dimethyl sulphoxide (DMSO) as the vehicle. 
• Among the synthesized compounds, 4d (N-methyl piperazinyl derivative), 
4g (N, N- dipropyl amino derivative) at 100µg/disc concentration was 
found to show mild activity against B.subtilis. 
• The compound 4b (morpholinyl derivative) at 100 µg/disc concentration 
was found to show mild activity against S. aureus.  
ANTIFUNGAL STUDIES 
All newly synthesized mannich bases were screened for antifungal activity 
against Candida albicans NCIM 3100 and Aspergillus niger NCIM 545 using 
Fluconazole (25 µg/disc) as standard and Dimethylsulphoxide (DMSO) as the 
vehicle. Concentrations of 100 µg/disc (saturated solution) of synthesized 
compounds were used for evaluating all the test compounds. All the compounds 
were found to be inactive against both the organisms. 
ANTI-OXIDANT STUDIES 
• Free radical scavenging activity was done by DPPH assay method using 
ascorbic acid as the standard. 
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• Among the newly synthesized compounds, Compound 4c  
(N- methyl aniline derivative) exhibited the maximum free radical 
scavenging activity at the final concentration of 0.2mM. 
• Among the tested compounds 4a (piperidinyl derivative), 4b  
(morpholinyl derivative), 4d ( N- methyl piperazinyl derivative), 4e (N, N-
dimethyl amino derivative), 4f (N, N-diethyl amino derivative), 4j (4-
flurophenyl amino derivative) showed free radical scavenging activity in 
the range 40-70%, while the rest showed less than 40%. 
• Ascorbic acid which was used as the standard in this screening showed 
free radical scavenging activity of 97% at 0.1mM concentration. None of 
the compounds exhibited superior activity compared to the standard 
ascorbic acid. 
CONCLUSION 
Based on the observations made from the results of synthetic work, 
characterization data, antimicrobial screening and screening of free radical 
scavenging activity, the following conclusions were drawn. 
¾ Microwave method of synthesis proved to be more efficient than the 
conventional method with respect to less reaction time and increased 
percentage yield of the product. This was especially observed for the N, 
N-dipropyl amino derivative 4g where the % yield of the product increased 
by 17% in microwave method of synthesis. 
¾ From the results obtained in the antibacterial screening, it was seen that, 
the presence of N-methyl piperazinyl substituent (4d) and N, N-
dipropylamino substituent (4g) in the mannich bases of quinazolione 
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imparted mild antibacterial activity against B. subtilis and the presence of 
morpholinyl substituent (4b) exerted mild activity against S. aureus. 
¾ Mannich bases of qunazolinyl having N-methylphenylamino substituent 
(4c) and N, N-dimethylamino substituent (4e) showed the highest free 
radical scavenging capacity for DPPH than the rest of the compounds 
synthesized. 
¾ Among the synthesized compounds 4d, 4g and 4b can be taken up as 
lead moieties for further structural modification to enhance the 
antibacterial activity.  
¾ Structural variation can be attempted on compound 4c and 4e for 
improving the antioxidant potential of the respective Mannich bases.    
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SUMMARY AND CONCLUSION 
SUMMARY 
Synthesis of 1-substituted-methyl-3-(2-phenyl-4-oxo-3-
quinazolinylimino)-1, 3-dihydro-indole-2-one  4(a-k) 
 
In this scheme eleven different isatin based mannich bases of quinazolin-
4-one were synthesized by four step process. 
¾ First step was the synthesis of 2- phenyl benzoxazin-4-one. 
¾ In the second step the benzoxazin-4-one was converted to  
3-amino-2-phenylquinazol-4-one by treating with hydrazine hydrate using 
ethanol as the solvent. 
¾ In the third step, Schiff’s base was synthesized by the condensation of the 
keto group of isatin with 3-amino-2-phenylquinazol-4-one. 
¾ In the fourth step, N- Mannich bases of the above Sciff’s base were 
synthesized by the reaction of amino group of isatin with formaldehyde 
and various primary and secondary amines. 
Yield of most of the derivatives by the conventional method (reaction time: 
1 hour) ranged from 60-72% and in the microwave method (reaction time: 3 min) 
ranged between 75-89%. Structures of the compounds were confirmed by UV, 
IR, PMR and Mass spectral datas. 
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 BIOLOGICAL ACTIVITY SCREENING 
Mannich bases of isatin are known to possess wide variety of biological 
activity. Hence the newly synthesized compounds were screened for 
antimicrobial and antioxidant activity. 
ANTIBACTERIAL STUDIES 
• Saturated concentration(100µg/disc) of all the test compounds were used 
and the results were compared with that of the standard Ciprofloxacin at 5 
mcg/disc concentration, against Gram positive and Gram negative 
bacteria using dimethyl sulphoxide (DMSO) as the vehicle. 
• Among the synthesized compounds, 4d (N-methyl piperazinyl derivative), 
4g (N, N- dipropyl amino derivative) at 100µg/disc concentration was 
found to show mild activity against B.subtilis. 
• The compound 4b (morpholinyl derivative) at 100 µg/disc concentration 
was found to show mild activity against S. aureus.  
ANTIFUNGAL STUDIES 
All newly synthesized mannich bases were screened for antifungal activity 
against Candida albicans NCIM 3100 and Aspergillus niger NCIM 545 using 
Fluconazole (25 µg/disc) as standard and Dimethylsulphoxide (DMSO) as the 
vehicle. Concentrations of 100 µg/disc (saturated solution) of synthesized 
compounds were used for evaluating all the test compounds. All the compounds 
were found to be inactive against both the organisms. 
ANTI-OXIDANT STUDIES 
• Free radical scavenging activity was done by DPPH assay method using 
ascorbic acid as the standard. 
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• Among the newly synthesized compounds, Compound 4c  
(N- methyl aniline derivative) exhibited the maximum free radical 
scavenging activity at the final concentration of 0.2mM. 
• Among the tested compounds 4a (piperidinyl derivative), 4b  
(morpholinyl derivative), 4d ( N- methyl piperazinyl derivative), 4e (N, N-
dimethyl amino derivative), 4f (N, N-diethyl amino derivative), 4j (4-
flurophenyl amino derivative) showed free radical scavenging activity in 
the range 40-70%, while the rest showed less than 40%. 
• Ascorbic acid which was used as the standard in this screening showed 
free radical scavenging activity of 97% at 0.1mM concentration. None of 
the compounds exhibited superior activity compared to the standard 
ascorbic acid. 
CONCLUSION 
Based on the observations made from the results of synthetic work, 
characterization data, antimicrobial screening and screening of free radical 
scavenging activity, the following conclusions were drawn. 
¾ Microwave method of synthesis proved to be more efficient than the 
conventional method with respect to less reaction time and increased 
percentage yield of the product. This was especially observed for the N, 
N-dipropyl amino derivative 4g where the % yield of the product increased 
by 17% in microwave method of synthesis. 
¾ From the results obtained in the antibacterial screening, it was seen that, 
the presence of N-methyl piperazinyl substituent (4d) and N, N-
dipropylamino substituent (4g) in the mannich bases of quinazolione 
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imparted mild antibacterial activity against B. subtilis and the presence of 
morpholinyl substituent (4b) exerted mild activity against S. aureus. 
¾ Mannich bases of qunazolinyl having N-methylphenylamino substituent 
(4c) and N, N-dimethylamino substituent (4e) showed the highest free 
radical scavenging capacity for DPPH than the rest of the compounds 
synthesized. 
¾ Among the synthesized compounds 4d, 4g and 4b can be taken up as 
lead moieties for further structural modification to enhance the 
antibacterial activity.  
¾ Structural variation can be attempted on compound 4c and 4e for 
improving the antioxidant potential of the respective Mannich bases.    
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LIST OF NEWLY SYNTHESIZED COMPOUNDS 
SCHEME - I 
N
N
O
N
N
R
O
 
1-substituted methyl-3-(2-phenyl-4-oxo-3-quinazolinylimino)-1, 
3- dihydro-indol-2-one  4 (a-k) 
COMPOUND 
CODE 
R CHEMICAL NAME 
IV a 
 
N
 
1-Piperidino-methyl-3-(2-phenyl-4-oxo-3-
quinazolinylimino)-1,3-dihydro-indole-2-
one 
IV b 
 
N O
 
1-Morpholino-methyl-3-(2-phenyl-4-oxo-3-
quinazolinylimino)-1,3-dihydro-indole-2-
one 
IV c 
 
N
H3C
 
 
1-(N-methy phenylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
IV d 
 
N N CH3
 
1-(N-methy piperazino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
IV e 
 
-N(CH3)2 
 
1-(N,N-dimethylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
IV f 
 
-N(C2H5)2 
1-(N,N-diethylamino)-methyl-3-(2-phenyl-
4-oxo-3-quinazolinylimino)-1,3-dihydro-
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indole-2-one 
IV g 
 
-N(C3H7)2 
1-(N,N-di-n-propylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
IV h 
 
NH Cl
 
1-(4-Chlorophenylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
IV i 
 
NH Br
 
1-(4-Bromophenylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
IV j NH F
1-(4-Fluorophenylamino)-methyl-3-(2-
phenyl-4-oxo-3-quinazolinylimino)-1,3-
dihydro-indole-2-one 
IV k NH
 
1-Phenylamino-methyl-3-(2-phenyl-4-
oxo-3-quinazolinylimino)-1,3-dihydro-
indole-2-one 
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